Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

The Twin Cities metro is home to some of the strongest and largest medical technology and device companies in the nation, ...

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE™ Platform for the treatment of drug ...

CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that ...

CEO Bernd Montag said the company is well positioned for a “U.S. versus China situation” that could arise when Donald Trump ...

BD (NYSE:BDX) shares ticked up before hours today on fourth-quarter results that came in ahead of the consensus forecast.

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

StarFish Medical, a leading North American full-service medical device development company, announced that it has acquired Omnica Corporation, a Southern California powerhouse in medical device design ...

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.

Freudenberg Medical is a global contract design and manufacturing partner to the medical device and biopharma industry with operations in Medtech hubs across the US, Europe, Asia and Costa Rica. The ...

Analyst Marie Thibault of BTIG maintained a Buy rating on Outset Medical (OM – Research Report), with a price target of $4.00. Marie ...